A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer

NCT00183807 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Insufficient Accrual

Conditions

Esophageal Cancer

Interventions

DRUG: irinotecan, cisplatin, celecoxib

Sponsor

University of Southern California

Collaborators

[object Object]